S&P 5007,765.36▼0.5% Nasdaq27,193.34▼1.2% Dow51,231.64▲0.1% Russell 2K2,794.13▲0.0% 10-Yr5.23%−5bp VIX15.41+0.33 WTI$91.10▲3.2% Gold$4,157.80▲0.4% EUR/USD1.122▼0.3% BTC$81,907▼1.4% Nikkei70,036▼0.9%
At close · Thu, Oct 8, 2026
Daily Market Updates.

Earnings

Home›Earnings›Previews›Eli Lilly price target raised after beat-and-raise qua…

Eli Lilly price target raised after beat-and-raise quarter

CNBC Earnings said strength in the company’s GLP-1 business indicates the stock may have further upside.

Reported · Written up by our desk · Previews

Eli Lilly’s stock price target was increased following another beat-and-raise quarter, according to CNBC Earnings.

The outlet pointed to ongoing strength in the company’s GLP-1 business, arguing it suggests the shares still have more room to run.

The update frames the latest results as confirmation of momentum in Eli Lilly’s GLP-1 franchise.

← Newer storyTreasuries hold steady after ISM impact, fuel prices steady

More like this

EarningsMicron shares slide on fears over Chinese memory competition
EarningsTesla debuts Cybercab and FSD tech in Europe at Paris Motor Show
EarningsAnthropic plans to share updated financials with investors this week
EarningsFlex launches Axiom AI modular data center racks
EarningsTexas Instruments rolls out AI data center chips ahead of Q3 earnings

Sources

CNBC EarningsWe're increasing our Eli Lilly price target after another beat-and-raise quarter

Get the close, explained.

One email every trading day: what moved, why it moved, and what's on deck tomorrow. Read in 3 minutes.

Free. Unsubscribe anytime.